Potential links between brown adipose tissue, circadian dysregulation, and suicide risk.

body mass index brown adipose fat tissue circadian disruption clozapine suicide risk

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2023
Historique:
received: 29 03 2023
accepted: 12 05 2023
medline: 26 6 2023
pubmed: 26 6 2023
entrez: 26 6 2023
Statut: epublish

Résumé

Circadian desynchronizations are associated with psychiatric disorders as well as with higher suicidal risk. Brown adipose tissue (BAT) is important in the regulation of body temperature and contributes to the homeostasis of the metabolic, cardiovascular, skeletal muscle or central nervous system. BAT is under neuronal, hormonal and immune control and secrets batokines: i.e., autocrine, paracrine and endocrine active substances. Moreover, BAT is involved in circadian system. Light, ambient temperature as well as exogen substances interact with BAT. Thus, a dysregulation of BAT can indirectly worsen psychiatric conditions and the risk of suicide, as one of previously suggested explanations for the seasonality of suicide rate. Furthermore, overactivation of BAT is associated with lower body weight and lower level of blood lipids. Reduced body mass index (BMI) or decrease in BMI respectively, as well as lower triglyceride concentrations were found to correlate with higher risk of suicide, however the findings are inconclusive. Hyperactivation or dysregulation of BAT in relation to the circadian system as a possible common factor is discussed. Interestingly, substances with proven efficacy in reducing suicidal risk, like clozapine or lithium, interact with BAT. The effects of clozapine on fat tissue are stronger and might differ qualitatively from other antipsychotics; however, the significance remains unclear. We suggest that BAT is involved in the brain/environment homeostasis and deserves attention from a psychiatric point of view. Better understanding of circadian disruptions and its mechanisms can contribute to personalized diagnostic and therapy as well as better assessment of suicide risk.

Identifiants

pubmed: 37360180
doi: 10.3389/fnins.2023.1196029
pmc: PMC10288144
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1196029

Informations de copyright

Copyright © 2023 Sarlon, Partonen and Lang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Mol Sci. 2023 Jan 10;24(2):
pubmed: 36674862
N Engl J Med. 2009 Apr 9;360(15):1509-17
pubmed: 19357406
J Affect Disord. 2015 Feb 1;172:403-9
pubmed: 25451444
PLoS One. 2013 Aug 26;8(8):e70109
pubmed: 23990898
Arch Intern Med. 2007 Mar 12;167(5):468-75
pubmed: 17353494
JAMA Psychiatry. 2014 Nov;71(11):1231-7
pubmed: 25208208
Science. 2010 Oct 15;330(6002):379-85
pubmed: 20947768
Brain Behav Immun. 2018 Mar;69:264-272
pubmed: 29197507
Neural Plast. 2017;2017:1504507
pubmed: 29230328
Transl Psychiatry. 2022 Aug 31;12(1):355
pubmed: 36045116
J Affect Disord. 2005 Nov;88(3):287-97
pubmed: 16181684
Genes Brain Behav. 2021 Apr;20(4):e12708
pubmed: 33070440
Biochim Biophys Acta. 2011 May;1813(5):878-88
pubmed: 21296109
Psychopharmacology (Berl). 2017 Nov;234(21):3259-3269
pubmed: 28812124
Nature. 2017 Jun 22;546(7659):544-548
pubmed: 28614293
FEBS Lett. 2005 Mar 14;579(7):1670-4
pubmed: 15757659
J Affect Disord. 2008 May;108(1-2):95-100
pubmed: 18029026
Brain Sci. 2022 Dec 01;12(12):
pubmed: 36552107
Front Physiol. 2022 Aug 09;13:870154
pubmed: 36017333
Transl Psychiatry. 2016 Nov 29;6(11):e963
pubmed: 27898069
Physiol Res. 2004;53(5):507-13
pubmed: 15479129
Int J Mol Sci. 2023 Jan 15;24(2):
pubmed: 36675212
Curr Obes Rep. 2022 Mar;11(1):1-9
pubmed: 34997461
Endocr Connect. 2021 Feb;10(2):R106-R115
pubmed: 33491659
Acta Psychiatr Scand. 2012 Feb;125(2):127-46
pubmed: 21838741
Nat Commun. 2011 Jun 21;2:356
pubmed: 21694704
Neurosci Biobehav Rev. 2021 Jul;126:79-101
pubmed: 33689801
Cell Metab. 2017 Apr 4;25(4):759-760
pubmed: 28380368
Am J Physiol Regul Integr Comp Physiol. 2012 May;302(9):R1049-58
pubmed: 22378771
Int J Bipolar Disord. 2021 Sep 1;9(1):26
pubmed: 34467430
Transl Psychiatry. 2022 Dec 1;12(1):497
pubmed: 36450713
Cell Metab. 2018 Jul 03;28(1):159-174.e11
pubmed: 29861389
Int J Environ Res Public Health. 2022 Nov 09;19(22):
pubmed: 36429454
BMC Psychiatry. 2021 Mar 16;21(1):153
pubmed: 33726707
Proc Natl Acad Sci U S A. 2015 May 26;112(21):6748-53
pubmed: 25964318
Auton Neurosci. 2022 Jan;237:102918
pubmed: 34823147
Horm Mol Biol Clin Investig. 2022 Oct 26;44(2):219-227
pubmed: 36288452
Nat Immunol. 2014 May;15(5):423-30
pubmed: 24681566
JCI Insight. 2021 Jun 8;6(11):
pubmed: 34100382
Can J Public Health. 1999 Nov-Dec;90(6):418-22
pubmed: 10680270
Cell. 2023 Jan 19;186(2):398-412.e17
pubmed: 36669474
Econ Hum Biol. 2022 Aug;46:101151
pubmed: 35717823
Front Endocrinol (Lausanne). 2020 Apr 21;11:222
pubmed: 32373072
J Therm Biol. 2021 Aug;100:102983
pubmed: 34503769
Front Pharmacol. 2022 Oct 03;13:984383
pubmed: 36263124
Compr Physiol. 2014 Oct;4(4):1677-713
pubmed: 25428857
Phytother Res. 2022 Jun;36(6):2495-2510
pubmed: 35445769
Life Sci. 2023 Jan 15;313:121273
pubmed: 36521548
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jan;1864(1):91-103
pubmed: 29859245
Cell Rep Med. 2023 Feb 21;4(2):100942
pubmed: 36812890
Neuroscience. 2006 Sep 15;141(4):2067-73
pubmed: 16814930
PLoS One. 2010 Feb 24;5(2):e9407
pubmed: 20195522
Mol Metab. 2022 Jan;55:101405
pubmed: 34844020
Biomol Concepts. 2012 Aug;3(4):381-386
pubmed: 23293681
J Clin Invest. 2013 Jan;123(1):215-23
pubmed: 23221344
Behav Brain Res. 2019 Dec 30;376:112186
pubmed: 31473283
J Neurosci. 2022 Oct 5;42(40):7659-7672
pubmed: 36194650
Biochem Pharmacol. 2021 Sep;191:114493
pubmed: 33647263
PLoS One. 2013 Aug 08;8(8):e71450
pubmed: 23951166
Psychoneuroendocrinology. 2022 Aug;142:105775
pubmed: 35594830
N Engl J Med. 2009 Apr 9;360(15):1500-8
pubmed: 19357405
J Endocrinol Invest. 2023 Mar;46(3):567-576
pubmed: 36242744
J Physiol. 2019 Mar;597(6):1439-1450
pubmed: 30615204
Nat Med. 2011 Feb;17(2):200-5
pubmed: 21258337
Cell. 2020 Sep 17;182(6):1660
pubmed: 32946784
Rev Endocr Metab Disord. 2019 Dec;20(4):387-397
pubmed: 31776853
J Neurosci. 2015 Feb 4;35(5):2181-90
pubmed: 25653373
Cell Rep. 2016 Aug 23;16(8):2231-2242
pubmed: 27524625
J Clin Psychiatry. 2021 Jan 19;82(2):
pubmed: 33471447
Cell Metab. 2011 Oct 5;14(4):478-90
pubmed: 21982708
J Affect Disord. 2022 Feb 1;298(Pt A):357-363
pubmed: 34774645
Front Neurol. 2012 Nov 05;3:157
pubmed: 23133436
Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E444-52
pubmed: 17473055
Ann Med. 2015 Mar;47(2):150-68
pubmed: 24915455
Front Physiol. 2019 Feb 13;10:94
pubmed: 30814954
Ann Med. 2013 Nov;45(7):465-6
pubmed: 24099037
J Therm Biol. 2019 May;82:178-185
pubmed: 31128645
Compr Physiol. 2017 Sep 12;7(4):1281-1306
pubmed: 28915325
Mol Psychiatry. 2015 Feb;20(1):48-55
pubmed: 25349171
Medicine (Baltimore). 2022 Dec 2;101(48):e32181
pubmed: 36482525
Nat Rev Genet. 2017 Mar;18(3):164-179
pubmed: 27990019
Sci Rep. 2022 Sep 21;12(1):15740
pubmed: 36131119
Nat Med. 2010 Sep;16(9):1001-8
pubmed: 20802499
Int J Biometeorol. 2014 Aug;58(6):1039-45
pubmed: 23775128
Curr Obes Rep. 2022 Jun;11(2):45-54
pubmed: 35174455
Int J Biometeorol. 2018 May;62(5):685-697
pubmed: 27822625
Endocrinology. 2021 Mar 1;162(3):
pubmed: 33453099
Exp Mol Med. 2012 Sep 30;44(9):545-53
pubmed: 22809901
J Anat. 1972 May;112(Pt 1):35-9
pubmed: 5086212
Psychiatr Serv. 2021 Aug 1;72(8):920-925
pubmed: 33882679
Best Pract Res Clin Endocrinol Metab. 2016 Aug;30(4):515-525
pubmed: 27697212
Neuropsychopharmacology. 2022 Mar;47(4):805-816
pubmed: 34837078
Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1218-27
pubmed: 27016501
Nat Commun. 2021 Aug 27;12(1):5163
pubmed: 34453052
Nat Rev Endocrinol. 2017 Jan;13(1):26-35
pubmed: 27616452
J Interferon Cytokine Res. 2021 Jul;41(7):258-267
pubmed: 34280025
Ann Med. 2015;47(7):527-9
pubmed: 26382179
Sci Total Environ. 2020 Mar 10;707:136053
pubmed: 31863976
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2011 Aug;27(3):348-52
pubmed: 22097733
J Affect Disord. 2018 Mar 1;228:132-142
pubmed: 29247901
J Biol Chem. 2022 Nov;298(11):102568
pubmed: 36209826
N Engl J Med. 2009 Apr 9;360(15):1518-25
pubmed: 19357407

Auteurs

Jan Sarlon (J)

University Psychiatric Clinics (UPK), University of Basel, Basel, Switzerland.

Timo Partonen (T)

Department of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.

Undine E Lang (UE)

University Psychiatric Clinics (UPK), University of Basel, Basel, Switzerland.

Classifications MeSH